Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.

Langenbeck's archives of surgery - 1 Apr 1999

Wenger F A, Zieren J, Peter F J, Jacobi C A, Müller J M

Abstract excerpt

BACKGROUND AND AIM: K-ras oncogene is the most promising molecular marker of pancreatic cancer. However, the incidence of single and combined K-ras mutations in stool and pancreatic tissue is unknown, and it is not clear whether detection of the K-ras oncogene in stool could be employed in screening tests. PATIENTS/METHODS: Stool and pancreatic tissue of patients with ductal adenocarcinoma (n = 36),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-19-9 Antigen
Share to Carcinoembryonic Antigen
Share to Carcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chronic Disease

Share to Mass Screening

Share to Pancreas

Share to Pancreatic Neoplasms

Share to Pancreatitis

Source

Identifiers

PMID: 10328172
DOI: 10.1007/s004230050189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.PMID 10328172Read ↗

Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.Semantic proximity Read ↗

Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool.Semantic proximity Read ↗

Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.Semantic proximity Read ↗

K-Ras mutations and benign pancreatic disease.Semantic proximity Read ↗

Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.Semantic proximity Read ↗

K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.Semantic proximity Read ↗

Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.Semantic proximity Read ↗

Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.Semantic proximity Read ↗

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.Semantic proximity Read ↗

Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53.Semantic proximity Read ↗

Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancerSemantic proximity Read ↗

p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.